Valter Longo, PhD Joins A4M/MMI 25th Annual World Congress on Anti-Aging Medicine in Las Vegas
Sep 20, 2017 20:22 pm UTC| Business
Boca Raton, Florida, Sept. 20, 2017 -- A4M/MMI has recently announced the addition of biochemist Valter Longo, PhD to its agenda for the 25th Annual World Congress in Las Vegas at the Venetian/Palazzo Resort, marking a...
Transocean Ltd. Receives Early Termination Notice on the Discoverer Clear Leader
Sep 20, 2017 20:15 pm UTC| Business
ZUG, Switzerland, Sept. 20, 2017 -- Transocean Ltd. (NYSE:RIG) announced today that a subsidiary of Chevron elected to exercise its contractual option to terminate the drilling contract for the ultra-deepwater drillship...
Dova Pharmaceuticals to Present at 2017 Leerink Partners Rare Disease Roundtable
Sep 20, 2017 20:15 pm UTC| Business
DURHAM, N.C., Sept. 20, 2017 -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the 2017 Leerink Partners Rare Disease...
Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel
Sep 20, 2017 20:15 pm UTC| Business
ROCKVILLE, Md., Sept. 20, 2017 -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the appointment of Alex Driggs to General Counsel and Corporate Secretary. Mr....
MDA’s ‘Live Unlimited’ Campaign Urges Americans to Support Families with Neuromuscular Disease
Sep 20, 2017 20:11 pm UTC| Business
Chicago, Sept. 20, 2017 -- The Muscular Dystrophy Association (MDA) today launched its 2017 “Live Unlimited” campaign set to run through Oct.11, 2017. The three-week awareness and fundraising campaign will feature the...
Meetinghouse Bancorp, Inc. Receives Shareholder Approval for Merger with Meridian Bancorp, Inc.
Sep 20, 2017 20:10 pm UTC| Business
BOSTON, Sept. 20, 2017 -- Meridian Bancorp, Inc. (“Meridian”) (NASDAQ:EBSB), the holding company for East Boston Savings Bank, and Meetinghouse Bancorp, Inc. (“Meetinghouse”) (OTC Pink:MTGB), the holding company for...
Corvus Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
Sep 20, 2017 20:10 pm UTC| Business
BURLINGAME, Calif., Sept. 20, 2017 -- Corvus Pharmaceuticals, Inc. (Nasdaq:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today...